Vaccine News and Research

Latest Vaccine News and Research

Sinusitis and bronchitis account for more than 30 million missed workdays each year

Sinusitis and bronchitis take a significant toll on a person's ability to participate in everyday life and have a sizable economic impact, accounting for more than 30 million missed workdays each year

21 Oct 2004

New law will help stop litigation abuse against vaccines

U.S. Senator Larry Craig announced that legislation will be signed into law in a few days by President Bush which will help avert future flu vaccine shortages.

21 Oct 2004

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

QIMR researchers have received a 5 year grant from the National Institutes of Health in the USA to develop a vaccine against Group A streptococcus. This extremely prestigious grant makes QIMR one of the most successful recipients of NIH funding in Australia.

18 Oct 2004

Campaign gives Florida residents 30,000 flu shots for free

Phones at Get Healthy Florida are ringing non-stop with people in search of the influenza vaccine. Calls are from mothers who have just received word that their children's pediatrician couldn't obtain the vaccine, and seniors who have gone from clinic to clinic only to find most shots are gone.

18 Oct 2004

Chiron responds to FDA announcement

Chiron Corporation last Friday provided the following statement in response to an announcement by U.S. health officials on the current influenza vaccine situation.

18 Oct 2004

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

Rheumatoid arthritis patients have an approximately two-fold increased morbidity and mortality in infections compared to a population without the disease.

18 Oct 2004

FDA finds Chiron influenza vaccine unsafe for use

The U.S. Food and Drug Administration has found that none of the influenza vaccine manufactured by the Chiron Corporation for the US market is safe for use.

16 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

New Jersey to receive additional flu vaccine

The New Jersey Department of Health and Senior Services (DHSS) received information on October 5, 2004 that, due to manufacturing problems in the United Kingdom, the United States will have only one-half of the expected supply of the influence vaccine available for this year’s flu season.

13 Oct 2004

Wisconsin has identified its first laboratory confirmed case of influenza this season

Public health officials in the department said the case, confirmed by the Wisconsin State Laboratory of Hygiene to be influenza type A (H3 subtype), involves an adult female from Waupaca County.

13 Oct 2004

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

MedImmune has announced that data from a preclinical study for its lead vaccine candidate to prevent respiratory syncytial virus (RSV) and parainfluenza virus type-3 (PIV-3) has shown a protective immune response against both viruses in animals.

13 Oct 2004

California issues alert and warning about flu vaccine price gouging

California State Attorney General Bill Lockyer has urged consumers and pharmacists to provide his office information about price gouging by flu vaccine suppliers and warned he will take enforcement action against those who exploit the supply shortage by charging unconscionable prices.

13 Oct 2004

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

The FDA and the U.K's MHRA have announced their intent to continue in a cooperative effort to address the manufacturing quality concerns related to the production of Chiron's influenza vaccine, Fluvirin, at the company's Liverpool facility.

13 Oct 2004

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

Flu shots have been around since World War II, and the Centers for Disease Control and Prevention has long recommended shots as a way to prevent influenza in the elderly. The approval of a new nasal spray vaccine begs the question whether those looking to stave off the flu should stick with the tried and true injection or switch to the nasal spray.

13 Oct 2004

CDC and Aventis Pasteur plan to allocate influenza vaccine

The Centers for Disease Control and Prevention (CDC) and Aventis Pasteur announced today the first phase of the plan to allocate influenza vaccine in response to the recently announced loss of half of the nation’s expected flu vaccine supply for the 2004-2005 season.

12 Oct 2004

New study offers rare glimpse of how the smallpox virus attacks its victims

Results of a new study in monkeys offer scientists a rare glimpse of how, on a molecular level, the smallpox virus attacks its victims. The findings shed light on how the virus caused mass death and suffering, and will help point the way to new diagnostics, vaccines and drugs that would be needed in the event of a smallpox bioterror incident.

12 Oct 2004

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

Examination of reports from the first two years after licensure of a new vaccine against pneumococcal infections indicates that the majority of adverse effects are minor, but that continued surveillance is warranted, according to a study in the October 13 issue of JAMA.

12 Oct 2004

A change in the national polio vaccination policy has led to the elimination of vaccine-associated paralytic poliomyelitis

The researchers found that from 1990 through 1999, 61 cases of paralytic polio were reported; 59 (97 percent) of these were VAPP (1 case per 2.9 million OPV doses distributed), 1 case was imported, and 1 case was indeterminate.

12 Oct 2004

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

11 Oct 2004

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

Prescriptions for antibiotics that could be taken in advance to prevent against anthrax were uncommon among concerned patients after September 11, 2001 and the 2001 U.S. anthrax attacks, according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Vaccine News and Research

Latest Vaccine News and Research

Sinusitis and bronchitis account for more than 30 million missed workdays each year

New law will help stop litigation abuse against vaccines

QIMR researchers have received a 5 year grant to develop a vaccine against Group A streptococcus

Campaign gives Florida residents 30,000 flu shots for free

Chiron responds to FDA announcement

Pneumococcal vaccinations help protect patients with rheumatoid arthritis against serious pneumococcal infections of the lungs, brain, blood, and ears

FDA finds Chiron influenza vaccine unsafe for use

Malaria vaccine candidate looks extremely promising

New Jersey to receive additional flu vaccine

Wisconsin has identified its first laboratory confirmed case of influenza this season

MedImmune progresses development of Respiratory Syncytial Virus and Parainfluenza Virus Type-3 vaccines

California issues alert and warning about flu vaccine price gouging

FDA and MHRA to cooperate efforts to address manufacturing concerns related Chiron's influenza vaccine

Influenza expert is beginning a three-year direct comparison of flu shots versus nasal spray flu vaccine

CDC and Aventis Pasteur plan to allocate influenza vaccine

New study offers rare glimpse of how the smallpox virus attacks its victims

Study finds new vaccine against pneumococcal has minor adverse effects but continued surveillance is warranted

A change in the national polio vaccination policy has led to the elimination of vaccine-associated paralytic poliomyelitis

Health care providers need to work together to ensure that high-risk individuals get the flu shot

Results do not suggest widespread anthrax antibiotic abuse in the aftermath of the 2001 terrorist attacks

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in